Action CenterAbout NCHLAVote TrackLegislative ReportsNCHLA Newslinks
 
     

 Abortion Non-Discrimination Act (ANDA)
 Assisted Suicide
 Born-Alive Infants Protection Act
 Child Custody Protection Act/CIANA
 Conscience Protection
 District of Columbia Abortion Funding
 Embryo/Fetal Research
 Federal Employees' Health Benefits (FEHB)
 Fetal Tissue Research
 Freedom of Access to Clinic Entrances (FACE)
 Freedom of Choice Act (FOCA)
 Health Care Reform
 Human Cloning
 Human Life Amendment
 Hyde Amendment
 Medical Training Non-Discrimination (ACGME)
 Mexico City Policy
 Military Abortion Policy
 Morning-After Pill
 Parental Involvement
 Partial-Birth Abortion
 Prison Abortion Funding
 Project Life and Liberty
 RU-486: Chemically Induced Abortion
 Stem Cell Research
 Terri Schiavo Dies
 Umbilical Cord Blood Banks
 Unborn Victims of Violence Act
 United Nations Population Fund (UNFPA)

RU-486: Chemically Induced Abortion

The drug commonly called RU-486 is used for chemically induced abortions. In the late 1990s, the U.S. House of Representatives passed bills that denied funding to the Food and Drug Administration (FDA) for the testing, development, or approval of any drug for chemical inducement of abortion. These measures were blocked in conference committee with the Senate.

On September 28, 2000, the FDA approved a regimen for using RU-486 to cause abortions within 49 days since the last menstrual period. RU-486 may be used in combination with the prostaglandin misoprostol. These drugs disrupt the uterine lining and cause the unborn child’s expulsion from the mother’s womb.

Subsequently, bills were introduced in Congress specifying physician qualifications to prescribe RU-486. The Bush Administration applied the Hyde funding restriction to RU-486. Amid ongoing concerns about safety of the drug for women using it, reports have surfaced about serious side-effects and even death. In 2003, a bill was introduced to suspend the approval of RU-486 while the Comptroller General reviews the special process under which the drug was approved.

Legislative Reports
Links to Other Web Sites
Click here to view Congressional Votes

Copyright 2002-2013 NCHLA